Abstract
A major limitation on the development of gene therapy and DNA vaccination protocols is the lack of efficient and safe gene delivery vectors. Although safer, non-viral gene delivery vectors must overcome a series of physical, enzymatic and diffusional barriers in order to reach the target cells nuclei. Following the strategy studied by our group, the objective of this project is the delop…